BROADWOOD CAPITAL INC Long-Term Concentrated

CIK: 0001278387 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value ($000): $1,310,241 (100.0% shares, 0.0% debt)

Holdings (8)

STAA STAAR SURGICAL CO 46.3%

Value ($000) $606,166 Shares 8,592,007 Est. Cost $8.21 Unrealized +942.4%

MNST MONSTER BEVERAGE CORP NEW 30.9%

Value ($000) $404,928 Shares 4,656,488 Est. Cost $22.71 Unrealized +102.9%

IWM ISHARES TR 8.7%

Value ($000) $113,795 Shares 690,000 Est. Cost $112.69 Unrealized —

AXON AXON ENTERPRISE INC 6.7%

Value ($000) $87,977 Shares 760,062 Est. Cost $27.50 Unrealized +312.2%

LCTX LINEAGE CELL THERAPEUTICS IN 3.0%

Value ($000) $39,477 Shares 34,935,485 Est. Cost $1.04 Unrealized +40.6%

— BTRS HOLDINGS INC 3.0%

Value ($000) $39,167 Shares 4,229,652 Est. Cost $5.23 Unrealized —

— ONCOCYTE CORP 1.3%

Value ($000) $17,048 Shares 23,353,697 Est. Cost $2.75 Unrealized —

— AGEX THERAPEUTICS INC 0.1%

Value ($000) $1,683 Shares 2,997,156 Est. Cost $2.99 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
STAA	STAAR SURGICAL CO	8,592,007	$606,166	46.3%	$8.21	+942.4%	COM PAR $0.01	852312305
MNST	MONSTER BEVERAGE CORP NEW	4,656,488	$404,928	30.9%	$22.71	+102.9%	COM	61174X109
IWM	ISHARES TR	690,000	$113,795	8.7%	$112.69	—	RUSSELL 2000 ETF	464287655
AXON	AXON ENTERPRISE INC	760,062	$87,977	6.7%	$27.50	+312.2%	COM	05464C101
LCTX	LINEAGE CELL THERAPEUTICS IN	34,935,485	$39,477	3.0%	$1.04	+40.6%	COM	53566P109
—	BTRS HOLDINGS INC	4,229,652	$39,167	3.0%	$5.23	—	COM CL 1	11778X104
—	ONCOCYTE CORP	23,353,697	$17,048	1.3%	$2.75	—	COM	68235C107
—	AGEX THERAPEUTICS INC	2,997,156	$1,683	0.1%	$2.99	—	COM	00848H108